PharmAust has appointed Westar Capital chairman Neville Bassett as a non-executive director, replacing Dr Wayne Best who is retiring. Dr Best will remain as chairman of the company’s wholly owned subsidiary Epichem. Pharmaust is poised to start clinical trials for its Monepantel anti-cancer drug on canine subjects soon.
Related Data & Insights
-
-
Rank Company Revenue 128th PharmAust $3.8m 137th Adisyn $2.9m 138th rent.com.au $2.8m 141st Douugh $2.5m 142nd Hazer Group $2.4m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
24 Apr 2024
Board Moves, April 24 2024
23 Apr 2024
PharmAust CEO resigns
05 Feb 2024
Board Moves February 5, 2024
28 Aug 2023
Board Moves August 28, 2023
29 Nov 2021
Board Moves November 29, 2021
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX